De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Walgreens Boots Alliance Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Tim Wentworth

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	0.003%
Management gemiddelde ambtstermijn	1.3yrs
Gemiddelde ambtstermijn bestuur	3yrs

Recente managementupdates

Recent updates

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Aug 13

Walgreens: A Painful Turnaround Lesson

Aug 02

Walgreens: Here's What Comes Next

Jul 09

Walgreens: Yielding Over 8% Following The Earnings Drop

Jul 02

Walgreens: Beware The Value Trap Ahead Of Earnings

Jun 24

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

May 30

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

May 22

Walgreens: Hold Tight, Let It Turn Around First

May 06

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

May 05

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Apr 10

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Apr 08

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

Apr 04

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Mar 27

Walgreens' Strategic Pivot

Mar 21

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Mar 15

Walgreens: New CEO Looking To Right The Ship

Feb 13

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Jan 19

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Jan 17

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

Jan 10

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

Dec 24

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Oct 31

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Oct 02

Walgreens Boots Alliance (NASDAQ:WBA) Will Pay A Dividend Of $0.48

Aug 01

Walgreens Boots Alliance (NASDAQ:WBA) Has Announced A Dividend Of $0.48

Jul 16

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Jul 04

CEO

Tim Wentworth (64 yo)

less than a year

Tenure

Mr. Timothy C. Wentworth, also known as Tim, served as Director of Ushur, Inc. since February 2022. He served as the Chief Executive Officer of Evernorth at Evernorth Health, Inc. (formerly known as Expres...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Stefano Pessina	Executive Chairman of the Board	12.5yrs	US$7.57m	0.076% $ 5.7m
Manmohan Mahajan	Executive VP & Global CFO	1.3yrs	US$1.83m	0.019% $ 1.5m
Ornella Barra	Chief Operating Officer of International	no data	US$5.43m	0.24% $ 17.7m
Timothy Wentworth	CEO & Director	less than a year	geen gegevens	0.0026% $ 198.7k
Todd Heckman	Senior VP	1.3yrs	geen gegevens	0.0010% $ 75.3k
Neal Sample	Executive VP & Chief Information Officer	less than a year	geen gegevens	geen gegevens
Tiffany Kanaga	Vice President of Global Investor Relations	no data	geen gegevens	geen gegevens
Matthew D'Ambrosio	Senior VP and Global Chief Compliance & Ethics Officer	no data	geen gegevens	geen gegevens
Lanesha Minnix	Executive VP & Global Chief Legal Officer	less than a year	geen gegevens	geen gegevens
Elizabeth Burger	Executive VP & Chief Human Resources Officer	no data	geen gegevens	geen gegevens
Liyue Wu	Head of M&A - Asia	no data	geen gegevens	geen gegevens
Tracey Brown	Executive VP	2.9yrs	geen gegevens	0.0030% $ 226.6k

1.3yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van WBA wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.3 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Stefano Pessina	Executive Chairman of the Board	12.5yrs	US$7.57m	0.076% $ 5.7m
Timothy Wentworth	CEO & Director	less than a year	geen gegevens	0.0026% $ 198.7k
Ginger Graham	Lead Independent Director	14.5yrs	US$366.85k	0.00025% $ 18.8k
Valerie Jarrett	Independent Director	4yrs	US$300.00k	0.00052% $ 39.1k
Nancy Schlichting	Independent Director	18yrs	US$319.97k	geen gegevens
John Lederer	Independent Director	9.5yrs	US$315.00k	0.0058% $ 435.9k
Bryan Hanson	Independent Director	2yrs	US$84.62k	0.0011% $ 84.3k
Janice Babiak	Independent Director	12.5yrs	US$325.00k	0.00014% $ 10.5k
William Shrank	Director	less than a year	geen gegevens	geen gegevens
Inderpal Bhandari	Independent Director	2.1yrs	US$115.29k	0.00035% $ 26.3k
Thomas Polen	Director	1.3yrs	US$14.13k	0.00020% $ 15.1k
Robert Huffines	Independent Director	less than a year	geen gegevens	geen gegevens

3.0yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van WBA wordt beschouwd als ervaren (gemiddelde ambtstermijn 3 jaar).

Walgreens Boots Alliance Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Walgreens Announces Executive Appointments

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Walgreens Boots Alliance, Inc. Announces Executive Changes

High number of new directors

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Recent updates

Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying

Saxena White P.A. Files New Securities Fraud Class Action Lawsuit Against Walgreens Boots Alliance, Inc. and Certain of its Executives

Price target decreased by 8.7% to US$12.43

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?

Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses

Is Walgreens Ready To Rebound?

Walgreens Announces Executive Appointments

Upcoming dividend of US$0.25 per share

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Walgreens: A Painful Turnaround Lesson

Gross Law Firm Announces Lawsuit Against Walgreens Boots Alliance, Inc

Third quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024

Walgreens: Here's What Comes Next

Walgreens: Yielding Over 8% Following The Earnings Drop

Boots Chief Quits Reportedly After Walgreens' Sale Plan Stalls

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target decreased by 9.0% to US$20.21

Consensus EPS estimates fall by 41%

Walgreens: Beware The Value Trap Ahead Of Earnings

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

Walgreens Announces Launch of Walgreens Brand Naloxone HCI Nasal Spray

Walgreens Reportedly Contacts Potential Buyers for £7 Billion Boots Drugstore Chain

Upcoming dividend of US$0.25 per share

Walgreens: Hold Tight, Let It Turn Around First

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Second quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

New major risk - Financial position

Consensus EPS estimates fall by 11%

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Walgreens' Strategic Pivot

Consensus EPS estimates increase by 11%

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Consensus EPS estimates fall by 14%

Walgreens: New CEO Looking To Right The Ship

Walgreens Boots Alliance, Inc. Announces Executive Changes

Upcoming dividend of US$0.25 per share at 4.4% yield

High number of new directors

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on March 12, 2024

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Walgreens Boots Alliance, Inc. to Report Q1, 2024 Results on Jan 04, 2024

Upcoming dividend of US$0.48 per share at 8.7% yield

Walgreens Boots Alliance Names Neal Sample Executive Vice President and Chief Information Officer

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2023

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings: EPS misses analyst expectations

Price target decreased by 10.0% to US$27.77

Walgreens Boots Alliance, Inc. Appoints Tim Wentworth as Chief Executive Officer, Effective October 23, 2023

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from S&P 100